StockTalk

General Category => ASX => Topic started by: lorraina on Aug 15, 2025, 09:03 AM

Title: AHC Austco Healthcare Ltd
Post by: lorraina on Aug 15, 2025, 09:03 AM
365,499,471 shares on issue.
MC at36.5 cents is $133,407,306
eps..026.....PE 13.57.
From DMX's latest newsletter;
Austco Healthcare (ASX:AHC), which provides healthcare communication and clinical workflow management
solutions globally, reported a strong finish to the year and positive full year results. FY25 was described by the
company as "a transformative year.... We delivered strong double-digit growth, successfully integrated
acquisitions, and executed our strategy with discipline". During FY25, AHC achieved revenue growth of ~40%
to $80m+, which resulted in ~60% growth in EBITDA to $13m, in part assisted by the full year contribution of
Amenco, which was acquired in April 2024 and performed ahead of expectations.
AHC now enters FY26 on track to deliver revenue in excess of $100m and NPAT of more than $10m. Pleasingly,
AHC's order book on 30 June 2025 of $55m is a record high, notwithstanding delivery of $13m of revenue in
June. With this increasing momentum and scale, AHC is well placed to continue its earnings and multiple rerate into FY26.


PS I note 2 posters I respect on HC are positive about the company./
Title: Re: AHC Austco Healthcare Ltd
Post by: Stoploss on Aug 15, 2025, 06:49 PM
Quote from: lorraina on Aug 15, 2025, 09:03 AM365,499,471 shares on issue.
MC at36.5 cents is $133,407,306
eps..026.....PE 13.57.
From DMX's latest newsletter;
Austco Healthcare (ASX:AHC), which provides healthcare communication and clinical workflow management
solutions globally, reported a strong finish to the year and positive full year results. FY25 was described by the
company as "a transformative year.... We delivered strong double-digit growth, successfully integrated
acquisitions, and executed our strategy with discipline". During FY25, AHC achieved revenue growth of ~40%
to $80m+, which resulted in ~60% growth in EBITDA to $13m, in part assisted by the full year contribution of
Amenco, which was acquired in April 2024 and performed ahead of expectations.
AHC now enters FY26 on track to deliver revenue in excess of $100m and NPAT of more than $10m. Pleasingly,
AHC's order book on 30 June 2025 of $55m is a record high, notwithstanding delivery of $13m of revenue in
June. With this increasing momentum and scale, AHC is well placed to continue its earnings and multiple rerate into FY26.


PS I note 2 posters I respect on HC are positive about the company./

Had a good run up to their latest release so I've been in and out .
Put the proceeds into 360.ax , going gangbusters .
Title: Re: AHC Austco Healthcare Ltd
Post by: lorraina on Sep 17, 2025, 11:06 AM
Annual report;
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02994316-3A676500&v=c2533a54e2514fb77a8f93f84db686e1125273e9
Title: Re: AHC Austco Healthcare Ltd
Post by: lorraina on Oct 29, 2025, 11:43 AM
Solid update.
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-03015377-3A680032&v=undefined
Title: Re: AHC Austco Healthcare Ltd
Post by: lorraina on Jan 13, 2026, 07:14 PM
https://www.youtube.com/watch?v=Vg9t8zSX9zY